Ovarian Cancer Treatment in Delhi

At CUSP we believe in providing the best quality of treatment for our patients

Cancer Surgeon

Expert Diagnosis, Personalised Treatment & Advanced Surgical Care at CUSP Group of Surgeons

Ovarian cancer is one of the most common gynaecological cancers and often develops silently, with symptoms appearing only in the later stages. It begins in the ovaries, the organs responsible for producing eggs and female hormones, and can spread to nearby organs or other parts of the abdomen if left untreated. Although ovarian cancer is challenging to detect early, advances in diagnostic techniques, surgery, and cancer therapies have significantly improved treatment outcomes.

CUSP Surgeons, is a team of highly experienced and skilled surgeons dedicated to delivering advanced surgical care with precision, safety, and compassion for cervical  cancer. Every patient receives a personalised treatment plan developed by a multidisciplinary team, combining advanced diagnostics, specialised cancer surgery, chemotherapy, and supportive care to achieve the best possible outcomes while preserving quality of life.

What is Ovarian Cancer?

Ovarian cancer occurs when abnormal cells within one or both ovaries grow uncontrollably and form a tumour. The ovaries are part of the female reproductive system and play an important role in producing eggs and hormones such as oestrogen and progesterone.

The most common type is epithelial ovarian cancer, which arises from the outer surface of the ovary and accounts for the majority of cases. Less common types include germ cell tumours and stromal tumours, which usually affect younger women and require specialised treatment.

In its early stages, ovarian cancer is often confined to the ovaries. As the disease progresses, it may spread to the lining of the abdomen, lymph nodes, or other organs. Early diagnosis and timely treatment are essential for improving long-term outcomes.

What Causes Ovarian Cancer?

The exact cause of ovarian cancer is not fully understood. However, several factors are known to increase the risk of developing the disease.

Common risk factors include:

  • Increasing age, particularly after menopause
  • Family history of ovarian, breast, or colorectal cancer
  • Inherited genetic mutations such as BRCA1 and BRCA2
  • Lynch syndrome
  • Never having been pregnant
  • Early onset of menstruation or late menopause
  • Endometriosis
  • Obesity

Having one or more of these risk factors does not necessarily mean a woman will develop ovarian cancer. However, women with a strong family history or inherited genetic conditions should discuss screening and risk assessment.

Why Early Diagnosis Matters

Ovarian cancer is often referred to as a “silent disease” because its early symptoms are vague and easily mistaken for common digestive or urinary conditions. As a result, many women are diagnosed only after the disease has spread beyond the ovaries.

What are the Symptoms of Ovarian Cancer?

Early ovarian cancer may cause few or no noticeable symptoms. As the tumour grows, women may experience:

  • Persistent abdominal bloating or swelling
  • Pelvic or abdominal pain
  • Feeling full quickly while eating
  • Loss of appetite
  • Frequent or urgent urination
  • Unexplained weight loss
  • Changes in bowel habits, including constipation
  • Fatigue
  • Menstrual irregularities in some women

These symptoms can also occur in many non-cancerous conditions. However, symptoms that persist for more than two to three weeks or become progressively worse should be evaluated by a specialist.

How is Ovarian Cancer Diagnosed?

Accurate diagnosis and staging are essential for determining the most appropriate treatment. At CUSP Group of Surgeons, diagnosis begins with a detailed medical history, pelvic examination, and advanced imaging to evaluate the ovaries and determine whether the disease has spread.

Diagnostic tests may include:

  • Pelvic Examination: To assess for ovarian enlargement or pelvic masses.
  • Ultrasound (Transvaginal or Abdominal): Helps identify ovarian cysts or tumours and evaluate their characteristics.
  • CT Scan or MRI: Provides detailed images to determine the size of the tumour and whether it has spread to nearby organs or lymph nodes.
  • CA-125 Blood Test: Measures a tumour marker that may be elevated in many women with ovarian cancer, although it is not specific for the disease.
  • Biopsy or Surgical Evaluation: A tissue sample obtained during surgery confirms the diagnosis and helps determine the type and stage of ovarian cancer.

Early and accurate diagnosis enables personalised treatment planning and improves the chances of successful treatment.

Treatment Options for Ovarian Cancer

Treatment for ovarian cancer depends on several factors, including the type of ovarian cancer, its stage, the extent of spread, the patient’s age, overall health, and future fertility considerations. At CUSP, every treatment plan is developed through a multidisciplinary approach involving gynaecologic cancer surgeons, medical oncologists, radiologists, pathologists, and supportive care specialists to provide personalised, evidence-based treatment.

  1. Surgery

Surgery is the cornerstone of treatment for most ovarian cancers. The primary goal is to remove all visible cancer while preserving healthy tissue whenever possible and improving the effectiveness of additional treatments such as chemotherapy.

  • Cytoreductive (Debulking) Surgery: This is the standard surgical treatment for many women with ovarian cancer. During this procedure, the surgeon removes as much of the tumour as possible, including affected tissues and nearby structures if necessary. Achieving complete or near-complete tumour removal plays a significant role in improving treatment outcomes and long-term survival.
  • Total Hysterectomy with Bilateral Salpingo-Oophorectomy: Depending on the stage of the disease, surgery may involve the removal of the uterus, both ovaries, and fallopian tubes, along with nearby lymph nodes and affected tissues within the abdomen. The extent of surgery is carefully determined based on the spread of the cancer and the patient’s overall condition.
  • Fertility-Preserving Surgery: For carefully selected women diagnosed with early-stage ovarian cancer who wish to have children in the future, fertility-preserving surgery may be considered. In such cases, only the affected ovary and fallopian tube may be removed while preserving the uterus and the healthy ovary whenever it is oncologically safe to do so.
  1. Minimally Invasive Surgery

In selected patients with early-stage ovarian cancer or suspicious ovarian masses, laparoscopic or robotic-assisted surgery may be performed. These minimally invasive techniques use small incisions and specialised instruments, offering several advantages over traditional open surgery.

Potential benefits include:

  • Smaller incisions with minimal scarring
  • Reduced blood loss
  • Less postoperative pain
  • Lower risk of complications
  • Shorter hospital stay
  • Faster recovery and earlier return to daily activities

The choice of surgical approach depends on the size of the tumour, stage of the disease, and current evidence-based treatment recommendations.

  1. Chemotherapy

Chemotherapy is an important part of ovarian cancer treatment and is commonly used after surgery to destroy any remaining cancer cells and reduce the risk of recurrence.

It may also be recommended:

  • Before surgery (Neoadjuvant Chemotherapy): To shrink large tumours and make surgery safer and more effective.
  • After surgery (Adjuvant Chemotherapy): To eliminate microscopic cancer cells that may remain after tumour removal.
  • For recurrent or advanced ovarian cancer: To control disease progression and relieve symptoms.
  1. Targeted Therapy

Targeted therapy uses medicines that specifically attack cancer cells by blocking the pathways responsible for tumour growth. These treatments are particularly beneficial for selected patients with BRCA gene mutations or other specific molecular characteristics.

Your treating team may recommend genetic and molecular testing to determine whether targeted therapy is appropriate as part of your treatment plan.

  1. Immunotherapy & Advanced Treatment Options

In selected cases of recurrent or advanced ovarian cancer, immunotherapy may be considered based on tumour biology and latest clinical evidence. These therapies aim to improve outcomes by enhancing the body’s immune response against cancer cells or targeting specific molecular pathways.

Comprehensive Follow-up & Survivorship Care

Regular follow-up is essential after ovarian cancer treatment to monitor recovery, detect any recurrence at an early stage, and address the long-term physical and emotional well-being of patients.

At CUSP Group of Surgeons, follow-up care includes periodic clinical evaluations, imaging when required, tumour marker assessment, nutritional guidance, and supportive care. 

Cashless Treatment & Government Health Schemes 

At CUSP Group of Surgeons & CUSP Cancer Care, we believe that financial concerns should never become a barrier to receiving timely cancer treatment. Through our empanelled partner hospitals, eligible patients can access cervical cancer treatment, cancer surgery, robotic surgery, and minimally invasive procedures under various Central Government, State Government, Defence, and Public Sector healthcare schemes.

Depending on the terms and eligibility of the respective scheme, patients may benefit from cashless hospitalization or reimbursement for approved treatments.

Our dedicated team assists eligible beneficiaries throughout the process, from documentation and approvals to admission and treatment coordination, ensuring a seamless healthcare experience.

We are associated with several government healthcare schemes, including:

  • Central Government Health Scheme (CGHS)
  • Ex-Servicemen Contributory Health Scheme (ECHS)
  • Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PM-JAY), where applicable
  • Ministry of Defence recognized healthcare support
  • ESI/ESIC (Employee’s State Insurance Corporation)
  • Multiple State Government Healthcare panels

Coverage and eligibility are subject to the terms and conditions of the respective healthcare scheme and the empanelled hospital.

Why Choose CUSP Group of Surgeons for Ovarian Cancer Treatment in New Delhi?

The successful treatment of ovarian cancer requires specialised surgical expertise, accurate staging, and coordinated multidisciplinary care. We provide personalised, evidence-based treatment using advanced surgical techniques and comprehensive oncology care to help patients achieve the best possible outcomes.

Patients choose CUSP Surgeons for:

  • High success rate: Advanced surgical expertise with successful patient outcomes. 
  • Experienced Surgical team: Trusted specialists in minimally invasive and GI surgeries. 
  • Personalized care: Tailored treatment plans focused on patient comfort and recovery. 
  • Advanced Laparoscopic techniques: Modern minimally invasive procedures with precision and safety. 
  • Faster recovery time: Smaller incisions, less pain, and quicker return to daily activities. 
  • Second Opinion consultations: Helping patients make informed surgical decisions with confidence. 

Our goal extends beyond treating cancer. We strive to restore health, improve quality of life, and help every patient return to their daily activities with confidence. 

Schedule Appointment

Fill out the form below, and we will be in touch shortly.
Contact Information
Patient Information
Preferred Date and Time Selection